Lynkuet vs Paroxetine for Hot Flashes: Which Should You Ask About First?
Educational research, not medical advice, and not medically reviewed by a clinician.
The short answer
Lynkuet (elinzanetant) and paroxetine (Brisdelle) are both FDA-approved, non-hormonal pills for menopausal hot flashes. In their studies, Lynkuet lowered hot flashes more — about 3.2 fewer per day than a placebo, versus roughly 0.9 to 1.7 fewer for low-dose paroxetine — and it costs far more (about $625/month without coverage) and requires liver blood tests. Paroxetine is much cheaper with a longer track record, but it shouldn’t be paired with tamoxifen and carries SSRI-class warnings.
Both calm hot flashes without hormones. But they’re not the same medicine, and they’re not for the same woman. The real question isn’t “which is better?” It’s which one is right for you— and that flips fast on three things: whether you take tamoxifen, what you can afford, and whether it’s the night sweats stealing your sleep that you most need to fix.
Lynkuet may fit better if… paroxetine may fit better if…
| Lynkuet may fit better if… | Paroxetine may fit better if… | |
|---|---|---|
| ✓ Best for | You want relief without an SSRI (antidepressant-type drug), night sweats are wrecking your sleep, and you can handle liver tests and a brand-drug price or copay card. | You need a low-cost or generic option, you’re noton tamoxifen, and you don’t have SSRI-specific red flags. |
| ✗ Not for you if | Cost is a hard limit, you can’t do lab work, you’re pregnant or could become pregnant, you have moderate-to-severe liver problems, or you take certain interacting drugs (strong CYP3A4 medicines or grapefruit). | You take tamoxifen, you’re worried about a hard withdrawal, or you take MAOI antidepressants, blood thinners, or other serotonin-raising drugs. |
Neither pill should be started without a clinician checking your pregnancy status, your full medication list, and your safety history first.
The right path isn’t the same for every woman
Use The HRT Index’s Find My HRT Path toolto match your situation to the right provider or option in about 90 seconds — and to flag if online care isn’t right for your situation.
Get your personalized action plan →Lynkuet vs paroxetine at a glance
Built from the FDA labels, trial data, and current pharmacy prices. Everything is dated. We tell you what we could not confirm further down. Last verified: July 2026.
| What you’re comparing | Lynkuet (elinzanetant) | Paroxetine (Brisdelle / generic) | What it means for you |
|---|---|---|---|
| What it is | A “dual neurokinin receptor antagonist” — it blocks two brain switches (NK1 and NK3) on the pathway that controls body temperature. Not a hormone. | An SSRI (selective serotonin reuptake inhibitor), a class usually used for mood. Not a hormone. The label says how it eases hot flashes isn’t fully known. | The real choice is brain-signal drug vs. antidepressant-type drug — not “hormone vs. non-hormone.” Both are non-hormonal. |
| FDA-approved for hot flashes? | Yes — approved Oct. 24, 2025. | Yes — Brisdelle approved June 2013; the first non-hormonal pill approved for hot flashes. | Both are legitimate, FDA-approved, non-hormonal options. Neither is compounded. |
| How you take it | 120 mg (two 60 mg capsules), once at bedtime. | 7.5 mg once at bedtime. | Both are simple bedtime pills. |
| How much it lowered hot flashes | About −3.2 per day vs. placebo at 12 weeks (OASIS 1 and 2). | About −0.9 per day (Trial 1) and −1.7 per day (Trial 2) vs. placebo at 12 weeks. | Lynkuet’s number is larger — but these came from separate studies, not a head-to-head test. |
| How fast | Some relief as early as 1 week. | Improvement often shows within about 4 weeks; can build up to ~3 months. | If you want faster movement, Lynkuet showed earlier changes in trials. |
| Helps sleep? | Built to help sleep too (the NK1 part targets night-time surges); trials measured sleep and showed improvement. | In its trials: cut VMS-related night wakings (39% vs. 28% on placebo) and added about 30 minutes of sleep. Not approved as a sleep drug. | Both have evidence. Lynkuet’s sleep benefit is more central to its design. |
| Cost without insurance | About $625/month (brand only, no generic). | Brand Brisdelle ~$200/month (~$52 with a discount card); generic paroxetine mesylate 7.5 mg ~$51–$70 with coupons. | Paroxetine is much cheaper. |
| Savings help | As little as $25/month with a commercial-insurance copay card (BlinkRx). Not for Medicare/Medicaid. May be free through Bayer’s assistance program. | Generic is usually a low, Tier-1 copay on most plans. | Your out-of-pocket depends heavily on insurance and program eligibility. |
| Required lab tests | Yes — liver blood tests before starting and again at 3 months. | None required by the label. | Lynkuet adds lab visits; paroxetine doesn’t. |
| Tamoxifen (breast cancer) | Processed by a different liver enzyme (CYP3A4), so it does not carry paroxetine’s tamoxifen conflict. Studied in women on breast-cancer hormone therapy — but breast cancer is not a separate approved use. | A strong CYP2D6 blocker — the standard advice is to avoid it with tamoxifen (it can weaken tamoxifen). | If you’re on tamoxifen, this often decides it. Talk to your oncologist. |
| Boxed warning | No boxed warning. Main flags: liver-enzyme rises, daytime drowsiness, pregnancy. | Boxed warning for suicidal thoughts/behavior (a class-wide SSRI warning). | Paroxetine’s boxed warning is standard for SSRIs; discuss mood history with your clinician. |
| Sexual side effects | Its label does not carry the SSRI sexual-dysfunction warning. | Label carries the SSRI class warning — though in the low-dose (7.5 mg) menopause trials, sexual dysfunction was not actually observed. | Worth discussing, but at this low dose the trial data were reassuring. |
| Stopping it | Not an SSRI — no SSRI-style withdrawal. | Stop slowly. The label lists withdrawal symptoms (vivid dreams, restlessness, trouble sleeping) if you quit suddenly. | If a hard taper worries you, that’s a point for the non-SSRI. |
| Weight gain | Not a listed common side effect. | In Brisdelle’s 7.5 mg trials, women did not report weight gain. | Neither is a weight-gain trap at these doses. |
| Generic available? | No — brand only for now. | Yes — generic paroxetine is widely available. | The cost gap is unlikely to close until Lynkuet gets a generic. |
Our editorial read
For raw hot-flash reduction, the numbers favor Lynkuet. For cost and track record, paroxetine wins — and it’s a genuinely solid option, not a runner-up. But for a huge share of women, the tiebreaker isn’t effectiveness at all — it’s whether you take tamoxifen, what you can pay, and whether broken sleep is the thing you most need fixed.
How do Lynkuet and paroxetine work differently?
How Lynkuet works
When estrogen drops in menopause, KNDy neurons (your body’s thermostat cells) start firing differently — linked to hot flashes. Lynkuet works right on that pathway, blocking NK1 and NK3 receptors. That’s why researchers call it “targeted.”
How paroxetine works
Paroxetine takes a side road. It’s an SSRI — keeping more serotonin available in the brain. At a low dose, it happens to reduce hot flashes. Even the FDA label admits the whyisn’t fully understood.
Two things follow from that difference:
- ›Different side effects. An SSRI brings SSRI baggage — a careful taper to stop, bleeding risk, a class warning for sexual side effects. Lynkuet brings its own list — drowsiness, liver monitoring.
- ›Different interactions. Paroxetine tangles with tamoxifen. Lynkuet tangles with grapefruit and certain CYP3A4 medicines.
Which one actually reduced hot flashes more?
| The trial evidence | Lynkuet | Paroxetine / Brisdelle |
|---|---|---|
| Who was in the studies | ~800 women with at least 50 moderate-to-severe hot flashes a week (OASIS 1 & 2), plus a 52-week safety study (OASIS 3). | ~1,175 postmenopausal women with at least 7–8 moderate-to-severe hot flashes a day (~50+ a week). |
| Fewer hot flashes than placebo, week 12 | About −3.2 per day in both OASIS 1 and OASIS 2. | About −0.9 per day (Trial 1) and −1.7 per day (Trial 2). |
| Within-study drop from baseline (OASIS 3) | −73.8% in hot-flash frequency vs. −47% on placebo. (A within-group percentage — not a cross-drug comparison.) | Trials reported the per-day numbers above, not this exact percentage. |
| Head-to-head test? | No. No study has put these two drugs against each other directly. | No. Same. |
| Indirect comparison | A 2026 network meta-analysis (BJOG) found elinzanetant more effective than paroxetine for hot-flash frequency. | The authors noted the result came from an indirect comparison — and the analysis was Bayer-supported. |
A quick, honest note on those numbers. Both drugs’ placebo groups also improved a lot — that’s normal in hot-flash research, the placebo effect is strong. What matters is the extrabenefit over placebo, and that’s where Lynkuet’s gap looks bigger. Supporting evidence from a 2024 Menopausejournal analysis found even fezolinetant (Veozah) — a cousin of Lynkuet — beat low-dose paroxetine on hot-flash frequency. So the pattern across studies points the same way. Just remember: it’s a pattern, not a photo finish.
Which is better for night sweats and broken sleep?
Lynkuet for sleep
Designed with sleep in mind. The NK1 half of the drug targets night-time surges and wake-ups, and its trials tracked sleep as a real outcome and showed improvement. Sleep benefit is central to its mechanism.
Paroxetine for sleep
Not a sleep pill, but don’t count it out. In its two big trials: cut night wakings blamed on hot flashes by 39% (vs. 28% on placebo) and increased nightly sleep by about half an hour— without leaving women groggier the next day.
Before your visit, ask yourself — and your clinician:
- ›How many hot flashes hit me during the day vs. at night?
- ›Are night sweats the main reason my sleep is shot, or is something else going on too?
- ›Could either pill leave me groggy the next day?
- ›Should I track my hot flashes (day and night) for two weeks so my clinician has real data?
That last one is quietly powerful. Two weeks of a simple tally turns “I feel awful” into numbers a clinician can act on fast.
What are the side effects — and which are worth worrying about?
Lynkuet’s common side effects (from its 52-week study, with placebo rates)
| Side effect | Lynkuet | Placebo |
|---|---|---|
| Headache | 9.6% | 7.0% |
| Fatigue | 7.3% | 2.9% |
| Dizziness | 6.1% | 1.9% |
| Drowsiness (somnolence) | 5.1% | 1.3% |
| Belly pain | 4.5% | 2.5% |
| Rash | 4.2% | 1.6% |
| Diarrhea | 3.8% | 1.0% |
| Muscle spasms | 3.2% | 0.6% |
Notice how close several of these are to placebo. For most women in the studies, Lynkuet didn’t feel wildly different from a sugar pill on side effects. The main real-world issues are the drowsiness (don’t drive until you know how it hits you) and the two liver tests. In Lynkuet’s own trials, liver-enzyme rises (ALT and/or AST at 3× the upper limit of normal) were uncommon — 0.6% on the drug vs. 0.4% on placebo. Real requirement, small trial signal. Both facts are true.
Paroxetine’s SSRI-class issues — the ones that change decisions
- ›Boxed warning: For suicidal thoughts and behavior — standard for all antidepressants. Discuss mood history with your clinician.
- ›Withdrawal: If you stop suddenly, the label lists symptoms like vivid dreams, restlessness, and trouble sleeping. You taper off with a clinician.
- ›Bleeding risk: Especially with aspirin, NSAIDs (like ibuprofen), or blood thinners.
- ›Serotonin syndrome: Risk if combined with other serotonin-raising drugs — and it should never be taken with MAOI antidepressants.
- ›Low sodium (hyponatremia): More of a concern in older women or those on certain water pills.
- ›Angle-closure glaucoma: In people at risk.
- ›Sexual side effects and weight gain: Carry the SSRI class warning — but the low-dose 7.5 mg trials did not actually show either.
None of these means paroxetine is a bad drug. But if any of them lands on a nerve for you, that nerve is information.
If you take tamoxifen or had breast cancer, what changes?
Tamoxifen is a “prodrug.” Your body has to convert it into its active, cancer-fighting form (endoxifen) using a liver enzyme called CYP2D6. Anything that blocks that enzyme can lower your endoxifen — and paroxetine is one of the strongest blockers there is. That’s why oncology and menopause guidance has long said: avoid paroxetine (and fluoxetine) for hot flashes if you’re on tamoxifen.
Simple decision logic
- ›On tamoxifen? Paroxetine is generally off the table. Ask your oncologist about Lynkuet, or another non-CYP2D6 option (like venlafaxine).
- ›Had breast cancer but on an aromatase inhibitor (not tamoxifen)? The CYP2D6 concern is less central. Now cost, sleep, and monitoring drive the choice — but still loop in your care team.
- ›No breast cancer history? Both are on the table. Decide on cost, monitoring, and which symptom hurts most.
Finding a provider who can handle both drugs and labs
Both drugs are prescription-only, and if you’re navigating tamoxifen or a cancer history, you want a clinician who knows these interactions and can order the liver labs the newer drug needs. Midi Healthis a menopause-focused telehealth practice available in all 50 states, in-network with most PPO plans. Their clinicians prescribe FDA-approved non-hormonal hot-flash options and order lab work — including for women who can’t take hormones, like breast cancer survivors.
What we verified (July 2026): available all 50 states; PPO in-network; prescribes FDA-approved non-hormonal options and orders labs. What we didn’t verify:whether Midi stocks Lynkuet by name in your state — ask during your visit. Cancer and tamoxifen decisions still go through your oncology team. Midi is not available to Medicaid patients; Medicare members can be seen as self-pay only.
Check whether Midi is in-network in your state →Disclosure: The HRT Index may earn a commission if you book through the link above, at no added cost to you. We don’t rank providers by payout — we route by fit first. If Midi isn’t a fit, Find My HRT Path will point you to a better-fit option.
What does Lynkuet cost vs. paroxetine?
| Your situation | Lynkuet (per month) | Paroxetine (per month) |
|---|---|---|
| Commercial insurance + copay card | As low as $25 (if covered; may need prior authorization) | Generic is usually a low, Tier-1 copay — verify with your plan |
| No insurance / cash, at the pharmacy | About $625 (the manufacturer’s stated cash price; some pharmacies list more) | Brand Brisdelle ~$200 (~$52 with a discount card); generic paroxetine mesylate 7.5 mg ~$51–$70 with coupons |
| No insurance + manufacturer help | Possibly $0 through Bayer’s assistance program, if you qualify | Generic is already low; some assistance programs exist |
| Medicare / Medicaid | Copay card not allowed; depends on your plan’s formulary | Generic usually covered at a low copay |
Prices verified July 2026 (Reuters, GoodRx, Drugs.com). Pharmacy prices change — confirm yours at the pharmacy.
One more note on generics: there’s a cheap generic paroxetine mesylate 7.5 mg (the direct Brisdelle equivalent) in the $51–$70 range with coupons. Some clinicians instead prescribe ordinary generic paroxetine tablets at a low dose off-label, which can run just a few dollars a month — but that’s a slightly different product than the FDA-approved 7.5 mg menopause capsule, so ask your clinician which one they mean.
When is Lynkuet the better one to ask about first?
Lean Lynkuet if:
- ✓Severe hot flashes or night sweats are the main event
- ✓You don’t want an antidepressant-class drug
- ✓A hard SSRI taper is a dealbreaker
- ✓You’re on tamoxifen (and cleared by oncology)
- ✓You can complete the liver tests
- ✓You have insurance or copay-card access — or qualify for free medication
If your feeling is “I want something non-hormonal, but I don’t want to start an antidepressant just for hot flashes,”that’s a completely reasonable thing to want — and Lynkuet is a completely reasonable thing to bring up. The consult isn’t about whether you “deserve” relief. You do. It’s about whether your labs, medications, and budget make Lynkuet a fit.
When does paroxetine still make more sense?
Lean paroxetine if:
- ✓You need the low-cost or generic path
- ✓You have no tamoxifen or CYP2D6 conflict
- ✓You’ve tolerated an SSRI before
- ✓You can’t access or afford Lynkuet, or can’t do its lab monitoring
- ✓Your clinician thinks a serotonin-based option fits your broader picture
What women say in reviews
Real, patient-written reviews from Drugs.com — shared here to reflect common concerns, not as proof of how well or safely the drug works.
One woman wrote that at first paroxetine was “the wonder drug, hot flashes gone,” but later felt it “not working as well.” Another said it cut her hot flashes sharply but “I found it impossible to sleep, I could not keep my hands and feet still.”None of that is a verdict — it’s the lived texture worth raising with your clinician.
When is online care NOT the right starting point?
Start with an in-person clinician or specialist first if you have:
- ›Active breast-cancer treatment decisions, or unresolved tamoxifen questions
- ›Abnormal liver tests, a history of liver disease, or moderate-to-severe liver problems
- ›A seizure history
- ›Any chance you could be pregnant (both drugs are avoided in pregnancy)
- ›Severe mood symptoms, thoughts of self-harm, or a history of mania or bipolar disorder
- ›A complex medication list — MAOI antidepressants, other serotonin-raising drugs, blood thinners, or strong CYP2D6/CYP3A4 medicines
- ›A risk of low sodium or narrow-angle glaucoma
- ›Symptoms that might not be menopause at all: unexplained fever, weight loss, a racing heart, or sweating that doesn’t fit the usual pattern
We’d rather send you to the right door than get the click. Find My HRT Path will flag that for you, too.
What to ask your clinician before you choose
Here’s a checklist you can screenshot and take with you.
Your symptoms
- ›How many moderate-to-severe hot flashes per day?
- ›How many night sweats per week?
- ›Are they waking you up?
- ›Any non-menopause red flags (fever, weight loss, racing heart)?
Your medications
- ›Every prescription, over-the-counter drug, and supplement.
- ›Tamoxifen? Other cancer medications?
- ›Any antidepressants (especially MAOIs), migraine triptans, St. John’s Wort, blood thinners, NSAIDs, or aspirin?
- ›Any strong CYP3A4 medicines? Do you drink grapefruit juice?
Your safety history
- ›Liver disease or abnormal liver tests?
- ›Seizure history?
- ›Any chance of pregnancy? (You’ll need reliable contraception on Lynkuet, including for 2 weeks after your last dose.)
- ›History of bipolar disorder or mania?
- ›Any thoughts of self-harm or major mood changes?
- ›Risk of low sodium or narrow-angle glaucoma?
Access and cost
- ›What insurance do you have?
- ›Does the drug need prior authorization?
- ›Do you qualify for manufacturer savings?
- ›Generic or brand?
The one sentence to bring:
“I’m comparing Lynkuet vs. paroxetine for moderate-to-severe hot flashes. Can we review my medication list, my tamoxifen status, my liver labs, my pregnancy status, and my cost path before we decide?”
How we verified this comparison
✓ What we actually verified (July 2026)
- ›Both drugs’ FDA approval, mechanism, dose, warnings, and interactions — from the FDA labels on DailyMed
- ›Lynkuet’s trial results (OASIS 1, 2, and 3) — from the FDA and the published JAMA trials
- ›Lynkuet’s exact side-effect rates, with placebo comparison — from its label
- ›Paroxetine/Brisdelle’s trial results, sleep data, and SSRI warnings — from its label and the published sleep analysis (Pinkerton et al., Menopause 2014)
- ›The paroxetine–tamoxifen (CYP2D6) interaction — from the Brisdelle label and peer-reviewed oncology guidance
- ›Lynkuet’s cost (~$625/month; $25 copay-card path) — from the manufacturer and Reuters
- ›Paroxetine/Brisdelle pricing — from GoodRx and Drugs.com
- ›The indirect Lynkuet-vs-paroxetine comparison — a 2026 BJOG network meta-analysis (noting it was Bayer-supported and not a head-to-head trial)
⚠️ What we could not verify (check these for your own case)
- ›Your final price after insurance, copay card, prior authorization, and pharmacy choice
- ›Whether a specific telehealth provider will prescribe a specific drug in your state
- ›Whether your personal medication list creates an interaction
- ›Whether online care is the right starting point for your history
Frequently asked questions
- Is Lynkuet better than paroxetine for hot flashes?
- The evidence favors Lynkuet for reducing hot-flash frequency — but there’s no head-to-head trial. In separate studies, Lynkuet cut moderate-to-severe hot flashes by about 3.2 more per day than a placebo did, versus about 0.9 to 1.7 fewer per day for low-dose paroxetine. “Better” still depends on your cost, tamoxifen status, and which symptom matters most.
- Is Lynkuet a hormone?
- No. Lynkuet (elinzanetant) is a non-hormonal drug that blocks two brain receptors (NK1 and NK3) on the pathway that controls body temperature. It is approved for moderate-to-severe hot flashes due to menopause.
- Lynkuet vs Brisdelle vs Paxil — what name should I ask for?
- Three names, easy to mix up. Lynkuet is the new NK-targeted drug (elinzanetant). Brisdelle is low-dose (7.5 mg) paroxetine, FDA-approved specifically for menopause hot flashes and not for mood — it has a cheaper generic (paroxetine mesylate 7.5 mg). Paxil is a higher-dose paroxetine used for depression and anxiety; some clinicians prescribe generic paroxetine tablets at a low dose off-label for hot flashes. If you want the FDA-approved menopause version, ask about Brisdelle or its 7.5 mg generic.
- Can I take paroxetine if I’m on tamoxifen?
- The standard advice is to avoid it. Paroxetine strongly blocks CYP2D6, the enzyme tamoxifen needs to become active, so it can weaken tamoxifen. Lynkuet uses a different pathway and does not carry that conflict — but any breast-cancer decision should go through your oncologist.
- Does Lynkuet require blood tests?
- Yes. Its label requires a liver blood test before you start and again at 3 months, and it is not started if your liver values are already high. Paroxetine requires no routine lab monitoring by its label.
- Which is cheaper, Lynkuet or paroxetine?
- Paroxetine, by a lot. Generic paroxetine mesylate 7.5 mg runs roughly $51–$70 per month with coupons; brand Brisdelle about $200 per month. Lynkuet runs about $625 per month without coverage — as low as $25 per month with a commercial copay card, which is not available for Medicare or Medicaid.
- How fast do Lynkuet and paroxetine work for hot flashes?
- Lynkuet showed relief as early as one week in trials. Paroxetine’s improvement often shows within about four weeks and can keep building for a few months.
- Will either one cause weight gain?
- In Brisdelle’s low-dose 7.5 mg hot-flash trials, women did not report weight gain. Weight gain is also not a listed common side effect of Lynkuet.
- What about sexual side effects?
- Paroxetine’s label carries the SSRI class warning for sexual side effects — but at the low 7.5 mg dose, the menopause trials did not actually show them. Lynkuet’s label does not carry that warning at all.
- Is Lynkuet safe, since it’s so new?
- It was approved in October 2025 after a large phase-3 program. Serious side effects were uncommon and close to placebo, and its trial liver signal was small (0.6% vs. 0.4%). But long-term, real-world data are still building — which is exactly why liver monitoring is required.
- Do either of these treat vaginal dryness or painful sex?
- No. These are for hot flashes and night sweats, not the full range of menopause symptoms. If dryness, urinary issues, or painful sex are part of your picture, ask specifically about treatments for those — they’re different.
- Do I need a doctor for either one?
- Yes. Both are prescription-only and need a clinical evaluation. A menopause-focused clinician can check your fit and order the labs Lynkuet requires.
- What if paroxetine stopped working for me?
- Some women report the effect fading over time. Options include reviewing your dose, switching medications, or trying an NK-targeted drug like Lynkuet — and paroxetine should be tapered, not stopped cold, to avoid withdrawal. A clinician can guide the switch.
The bottom line
Lynkuet and paroxetine are both real, FDA-approved, non-hormonal ways to fight hot flashes. Lynkuet tends to work more, but it’s pricey and needs lab tests. Paroxetine is cheap and proven — with genuine hot-flash and sleep data — but it clashes with tamoxifen and carries SSRI-class warnings. There’s no universal winner. Just the right fit for your budget, your history, and your symptoms.
Also compare: Lynkuet vs gabapentin · Veozah vs paroxetine · Veozah vs Lynkuet · All non-hormonal options
Still not sure which HRT program is right for you? Take our free Find My HRT Path matching quiz — about 90 seconds.
Start Find My HRT Path →The HRT Index is an independent decision resource for online menopause and HRT care for women. This page is educational research and is not medical advice and not medically reviewed by a clinician. FDA-approved and compounded medications are always kept distinct; nothing here implies a compounded product is equivalent to, safer than, or more natural than an FDA-approved one. Always talk with a licensed clinician before starting, stopping, or changing any medication. Prices and drug labels change — see the “Last verified” date above.
Affiliate disclosure: The HRT Index is reader-supported. If you book with a provider through our links, we may earn a commission at no additional cost to you. This never affects our medical facts, our verification, or which option we say fits you.
Last verified: July 2026. Pricing, insurance coverage, savings-card terms, FDA labeling, and provider availability can change. The HRT Index re-checks top medication and provider pages monthly under The HRT Index Verification Standard.